A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
2 other identifiers
interventional
250
2 countries
51
Brief Summary
To evaluate the clinical, immunologic, and virologic effects of oral zidovudine (AZT) plus intravenous immunoglobulin (IVIG) versus AZT plus placebo (albumin). It is estimated that by 1991, there may be 10,000 to 20,000 HIV-infected children in the United States. HIV infection in children is most often associated with symptomatic disease and poor prognosis. Treatment with antiviral therapy may be effective in changing the course of disease and decreasing mortality in this vulnerable population. AZT treatment has been shown to decrease mortality and the frequency of opportunistic infections in certain adult AIDS patients; therefore, it is likely that children may also benefit from this antiviral therapy. In addition, bacterial infections are frequently found in HIV-infected children. Because pooled human serum immunoglobulin, another name for antibodies, is effective in reducing bacterial infection in patients with defects of immunity, it may reduce the rate of bacterial infection in HIV-infected children as well. In this study, AZT will be administered together with IVIG to determine safety, tolerance, and efficacy of the combined treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 hiv-infections
51 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Completion
Last participant's last visit for all outcomes
April 1, 1993
CompletedFirst Submitted
Initial submission to the registry
November 2, 1999
CompletedFirst Posted
Study publicly available on registry
August 31, 2001
CompletedNovember 3, 2021
October 1, 2021
November 2, 1999
October 27, 2021
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Concurrent Medication:
- Allowed:
- Benadryl and/or acetaminophen may be given before and during intravenous immunoglobulin (IVIG) infusion in patients demonstrating mild reactions during infusion.
- Acetaminophen for short-term fever and pain.
- Zidovudine (AZT).
- Steroids.
- Oral or systemic (swish and swallow) nystatin.
- Maintenance therapy for fungal disease or tuberculosis.
- Prophylaxis for a previous episode of Pneumocystis carinii pneumonia (PCP) including the use of trimethoprim / sulfamethoxazole (TMP / SMX). The dosage is specified as TMP 75 mg/m2 twice daily 3 times a week and SMX 375 mg/m2 twice daily 3 times a week.
- Recommended:
- Children with AIDS and / or CD4 count = or \< 500 cells/mm3 should receive primary PCP prophylaxis as described.
- Concurrent Treatment:
- Allowed:
- Blood transfusion for hemoglobin \< 8 g/dl and hematocrit \< 24 percent or bone marrow suppression.
- Supplemental oxygen with a prestudy PaO2 \< 70 mmHg.
- +7 more criteria
You may not qualify if:
- Co-existing Condition:
- Patients with the following will be excluded:
- Lymphoid interstitial proliferation (LIP) not requiring steroids and supplemental oxygen or with other lymphoproliferative diseases as their sole clinical evidence of HIV infection.
- Known hypersensitivity to immunoglobulin.
- Active HIV thrombocytopenia requiring IVIG therapy.
- Concurrent Medication:
- Excluded:
- Chronic acetaminophen.
- Drugs that are metabolized by hepatic glucuronidation should not be used for more than 24 hours without notifying the study physician.
- Antibacterial prophylaxis for otitis, sinusitis, or urinary tract infection.
- Prophylaxis treatment for Pneumocystis carinii pneumonia (PCP) prior to the first episode of laboratory-documented PCP.
- Immunoglobulin (IVIG) therapy required for active HIV thrombocytopenia.
- Patients with the following will be excluded:
- Lymphoid interstitial proliferation (LIP) not requiring steroids and supplemental oxygen or with other lymphoproliferative diseases as their sole clinical evidence of HIV infection.
- Known hypersensitivity to immunoglobulin.
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (51)
Kaiser Permanente / UCLA Med Ctr
Downey, California, 902422814, United States
Long Beach Memorial (Pediatric)
Long Beach, California, 90801, United States
Children's Hosp of Los Angeles/UCLA Med Ctr
Los Angeles, California, 900276016, United States
Los Angeles County - USC Med Ctr
Los Angeles, California, 90033, United States
Cedars Sinai / UCLA Med Ctr
Los Angeles, California, 900481804, United States
Martin Luther King Jr Gen Hosp / UCLA Med Ctr
Los Angeles, California, 900593019, United States
UCLA Med Ctr / Pediatric
Los Angeles, California, 900951752, United States
Stanford Univ School of Medicine
Menlo Park, California, 94025, United States
Children's Hosp of Oakland
Oakland, California, 946091809, United States
Univ of California / San Diego Treatment Ctr
San Diego, California, 921036325, United States
Northern California Pediatric AIDS Treatment Ctr / UCSF
San Francisco, California, 94143, United States
Olive View Med Ctr
Sylmar, California, 91342, United States
Univ of Connecticut Health Ctr / Pediatrics
Farmington, Connecticut, 06032, United States
Emory Univ School of Medicine
Atlanta, Georgia, 30303, United States
Cook County Hosp
Chicago, Illinois, 60612, United States
Univ of Illinois College of Medicine
Chicago, Illinois, 60612, United States
Chicago Children's Memorial Hosp
Chicago, Illinois, 606143394, United States
Tulane Univ School of Medicine
New Orleans, Louisiana, 70112, United States
Univ of Maryland at Baltimore / Univ Med Ctr
Baltimore, Maryland, 21201, United States
Children's Hosp of Boston
Boston, Massachusetts, 021155724, United States
Boston Med Ctr
Boston, Massachusetts, 02118, United States
Univ of Massachusetts Med Ctr
Worcester, Massachusetts, 01655, United States
Univ of Minnesota
Minneapolis, Minnesota, 55455, United States
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl
Newark, New Jersey, 071072198, United States
SUNY / Health Sciences Ctr at Brooklyn / Pediatrics
Brooklyn, New York, 11203, United States
City Hosp Ctr at Elmhurst / Mount Sinai Hosp
Elmhurst, New York, 11373, United States
Schneider Children's Hosp / Long Island Jewish Med Ctr
New Hyde Park, New York, 11042, United States
Beth Israel Med Ctr / Pediatrics
New York, New York, 10003, United States
Bellevue Hosp / New York Univ Med Ctr
New York, New York, 10016, United States
Saint Luke's - Roosevelt Hosp Ctr
New York, New York, 10025, United States
Metropolitan Hosp Ctr
New York, New York, 10029, United States
Mount Sinai Med Ctr
New York, New York, 10029, United States
Columbia Univ Babies' Hosp
New York, New York, 10032, United States
Harlem Hosp Ctr
New York, New York, 10037, United States
Univ of Rochester Medical Center
Rochester, New York, 14642, United States
Lincoln Hosp Ctr / Pediatrics
The Bronx, New York, 10451, United States
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Westchester Hosp / New York Med College / Pediatrics
Valhalla, New York, 10595, United States
Duke Univ Med Ctr
Durham, North Carolina, 277103499, United States
Holmes Hosp / Univ of Cincinnati Med Ctr
Cincinnati, Ohio, 452670405, United States
Univ Hosp of Cleveland / Case Western Reserve Univ
Cleveland, Ohio, 44106, United States
Columbus Children's Hosp
Columbus, Ohio, 432052696, United States
Ohio State Univ Hosp Clinic
Columbus, Ohio, 432101228, United States
Saint Christopher's Hosp for Children
Philadelphia, Pennsylvania, 191341095, United States
Julio Arroyo
West Columbia, South Carolina, 29169, United States
Hermann Hosp / Univ Texas Health Science Ctr
Houston, Texas, 77030, United States
Texas Children's Hosp / Baylor Univ
Houston, Texas, 77030, United States
Children's Hosp of Seattle
Seattle, Washington, 98105, United States
Ramon Ruiz Arnau Univ Hosp / Pediatrics
Bayamón, 00619, Puerto Rico
San Juan City Hosp
San Juan, 009367344, Puerto Rico
UPR Children's Hosp / San Juan City Hosp
San Juan, 00936, Puerto Rico
Related Publications (5)
Connor E, McSherry G. Treatment of HIV infection in infancy. Clin Perinatol. 1994 Mar;21(1):163-77.
PMID: 7912175BACKGROUNDMofenson LM, Moye J Jr. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection. Pediatr Res. 1993 Jan;33(1 Suppl):S80-7; discussion S87-9. doi: 10.1203/00006450-199305001-00464.
PMID: 8433880BACKGROUNDPerrier M, Schwarz T, Gonzalez O, Brounts S. Squamous cell carcinoma invading the right temporomandibular joint in a Belgian mare. Can Vet J. 2010 Aug;51(8):885-7.
PMID: 21037891BACKGROUNDSpector SA, Gelber RD, McGrath N, Connor EM, Wara DW, Balsley JF. Results of a double-blind placebo-controlled trial to evaluate intravenous gamma globulin in children with symptomatic HIV infection receiving zidovudine (ACTG 051). The Pediatric AIDS Clinical Trials Group and the NICHD Pediatric HIV Centers. Int Conf AIDS. 1993 Jun 6-11;9(1):48 (abstract no WS-B05-6)
BACKGROUNDSpector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med. 1994 Nov 3;331(18):1181-7. doi: 10.1056/NEJM199411033311802.
PMID: 7935655BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Spector, SA